To address this latter point, circulating levels of inflammatory cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor-α should be measured in both BA patients with low and high circulating CLU levels. The gene discussed is IL6; the disease is breast angiosarcoma.